Wegovy Pill Price: What the New GLP-1 Weight Loss Pill Actually Costs in the U.S.
Novo Nordisk has officially launched the first-ever GLP-1 pill for obesity in the United States—and for once, the headline isn’t…
Category: Research Insights
The Science Behind Oral GLP-1 Therapies
Oral GLP-1 receptor agonists (like semaglutide tablets) work in the same way as injectable GLP-1 drugs, but with some differences…
How Stress and Social Struggles Are Fueling America’s Obesity Crisis
Obesity rates in the United States continue to climb at an alarming pace — and experts say it’s not just…
Ozempic May Put Young Women and Their Pregnancies at Risk
Weight-loss drugs like Ozempic and Wegovy are changing the way millions approach health and body weight. But new research warns…
WHO Adds GLP-1 Drugs to Essential Medicines List: What It Means for Global Diabetes Care
In a move that could reshape global diabetes treatment, the World Health Organization (WHO) has officially added GLP-1 receptor agonists—the…
The Next Ozempic? Tufts’ 4-in-1 Weight Loss Drug Could Redefine Obesity Treatment
Weight loss science is entering a new era. For years, drugs like Ozempic and Wegovy have transformed how doctors treat…
Eli Lilly’s experimental weight loss pill, orforglipron phase 3 clinical trial result update
Eli Lilly’s experimental once-daily pill, orforglipron, has shown promising Phase 3 trial results, helping over 3,000 adults lose an average…